June 12, 2013

Google has removed advertisements for websites that sell drugs without prescriptions, following a series of warning letters from a state attorney general, according to published reports.

June 12, 2013

Pharmacy automation provider QS/1 has received certification for controlled substances prescribed electronically, the company said.

June 12, 2013

Walgreens on Wednesday reached an agreement settling DEA concerns relating to the distribution and dispensing of controlled substances.

June 11, 2013

The emergency contraceptive Plan B (the original two-tablet formulation) can now be sold as an OTC without any sales restrictions as the Obama administration concedes its fight to prevent nonprescription access to younger teenage girls. And soon the newer Plan B One Step (one tablet) will be available without sales restrictions as well.

June 11, 2013

Fruth Pharmacy has launched a new mobile app and mobile website, the retail pharmacy chain said.

June 10, 2013

Anglo-Swedish drug maker AstraZeneca will pay up to $1.15 billion for a U.S. developer of drugs for respiratory diseases, AstraZeneca said Monday.

June 10, 2013

A 26-member joint panel comprising the Food and Drug Administration's Endocrinologic and Metabolic Drugs and Drug Safety and Risk Management advisory committees voted to support modifying or removing the risk evaluation and mitigation strategy protocol for GlaxoSmithKline's Type 2 diabetes drug Avandia (rosiglitazone).

Historically, the FDA has followed advisory committee votes when making a decision on the marketing of a drug even though it is not bound by them, but assuming the agency follows the panel's advice, it could mean a lot for the controversial drug and the way it's dispensed. But even if Avandia winds up on retail pharmacy shelves again, it faces a very different landscape from its heyday.

June 10, 2013

With a striking new pharmacy design and workflow system that pulls the pharmacist out from behind the counter and right into the patient waiting area, the nation’s top pharmacy retailer is helping to drive healthcare reform and the accelerating revolution in pharmacy-based patient care.

June 7, 2013

A joint Food and Drug Administration expert panel voted to recommend keeping a controversial GlaxoSmithKline diabetes drug available for certain patients, GSK said.

June 7, 2013

The Council for Responsible Nutrition strongly criticized the Center for Science in the Public Interest earlier this week as that organization petitioned the Food and Drug Administration to prohibit the sale of Ginkgo biloba.

June 6, 2013

The Food and Drug Administration has approved a drug made by Celgene for treating a type of cancer.

June 6, 2013

Rite Aid's same-store sales decreased by 1.5% in May as the shift to generic drugs continued to offset front-end comps, the retail pharmacy chain said.

June 5, 2013

South Korean drug maker Hanmi Pharmaceutical Co. and U.S. partner Amneal Pharmaceuticals have made an agreement in federal court concerning a generic heartburn drug.

June 5, 2013

Walgreens posted third-quarter sales of $18.3 billion, up 3.3%.

June 4, 2013

The House of Representatives voted Monday to pass a bill that would establish national standards for the pharmaceutical supply chain.

June 4, 2013

A lot is said about how pharmacists are the most accessible healthcare professionals, and one health insurer is taking advantage of this by sponsoring a series of special seminars for elderly people.

June 4, 2013

A subsidiary of Aceto Corp. has launched a generic treatment for seasonal and perennial allergies, the company said Tuesday.

June 3, 2013

Retail pharmacists will be missing out on as much as a $20 billion opportunity if they don't identify how to consistently and efficiently engage their patients, suggested Jeff Rehling, principal at Edgewood Consulting Group, during a business session Sunday at the recent 2013 GMDC Health & Wellness @ Retail Conference.

June 3, 2013

The state attorney general of New York is urging health insurers to let patients buy specialty drugs through retail pharmacies instead of having to use mail-order.

June 3, 2013

Efforts to create a generic top-level domain for legitimate pharmacy websites gained traction last week when the Internet Corporation for Assigned Names and Numbers, or ICANN - the body that controls what goes into Internet URLs - gave the National Association of Boards of Pharmacy a passing grade for an initial evaluation of its plans for the domain, ".pharmacy."

If successful, the .pharmacy domain will create a powerful new weapon to combat the rise of illegal online pharmacies, which, according to many studies, constitute all but 3% of the websites selling drugs on the Internet. These are the "Canadian" pharmacies selling cheap drugs that one often sees links to on search engines and other websites; despite their supposed provenance, they're usually based in countries where regulations are lax or unenforced.

May 31, 2013

Out of all retail pharmacy outlets, food stores have slightly increased their prescription sales, generating March year-to-date sales of $5.7 billion, up 0.5%, according to IMS Health data. Including drug, mail and independents, prescription sales totaled $58.3 billion, down 4.7%, reported Doug Long, VP industry relations for IMS Health, at an FMI education breakout.

May 30, 2013

Beauty trends are as much a reflection of the consumer's state of mind as they are a reflection of the technological innovations put forth by research-and-development teams at laboratories around the world. While consumers are not able to verbalize their expectations for the ideal product that will fulfill their needs, they are able to pinpoint gaps with their unmet needs through their purchasing patterns.

May 30, 2013

When does the double-edged sword of generic drug price reductions begin to cut the government agency or health system holding the sword?

That's the question many pharmacy leaders in Canada have for the provincial health system policy-makers who have embarked on a crusade to whack pharmacy reimbursement levels for many lower-cost generic medicines sold under the nation's publicly funded health system.

May 30, 2013

This summer, the Supreme Court will decide on a case that could determine whether generic drug makers can be held liable when patients suffer harmful side effects from taking their drugs.